πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 88 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 11885807

Method for depleting malignant T-cells

AUTOLUS LIMITED Β· Granted Tue Jan 30 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11878062

Multimeric T-cell modulatory polypeptides and methods of use thereof

Cue Biopharma, Inc. Β· Granted Tue Jan 23 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 18 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11879003

Methods for increasing T-cell function

Kyverna Therapeutics, Inc. Β· Granted Tue Jan 23 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 18 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11851672

CAR T-cells comprising transcriptional circuits

AUTOLUS LIMITED Β· Granted Tue Dec 26 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 21 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11851471

T-cell modulatory multimeric polypeptides and methods of use thereof

Cue Biopharma, Inc. Β· Granted Tue Dec 26 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 21 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11851467

T-cell modulatory multimeric polypeptides and methods of use thereof

Cue Biopharma, Inc. Β· Granted Tue Dec 26 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 21 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11850264

Gamma delta T-cell receptor and its ligand

University College Cardiff Consultants Limited Β· Granted Tue Dec 26 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 21 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11786582

Human application of engineered chimeric antigen receptor (CAR) T-cells

The Board of Regents of the University of Texas System Β· Granted Tue Oct 17 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11739133

T-cell modulatory multimeric polypeptides and methods of use thereof

Cue Biopharma, Inc. Β· Granted Tue Aug 29 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 24 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11725039

Ξ±/Ξ² t-cell receptor and methods of using it

University College Cardiff Consultants Limited Β· Granted Tue Aug 15 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 10 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11713446

Processes for generating TIL products enriched for tumor antigen-specific T-cells

Iovance Biotherapeutics, Inc. Β· Granted Tue Aug 01 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 27 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11708400

T-cell modulatory multimeric polypeptides and methods of use thereof

Cue Biopharma, Inc. Β· Granted Tue Jul 25 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 20 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11702461

T-cell modulatory multimeric polypeptides comprising reduced-affinity immunomodulatory pol

Cue Biopharma, Inc. Β· Granted Tue Jul 18 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 13 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11603519

T-cell receptor

Takeda Pharmaceutical Company Limited Β· Granted Tue Mar 14 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11597773

CD6 antibody for treatment of T-cell mediated diseases or disorders

THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted Tue Mar 07 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11548945

T-cell receptor (TCR)-binding antibodies and uses thereof

The Board of Regents of the University of Texas System Β· Granted Tue Jan 10 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 05 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11530248

T-cell modulatory multimeric polypeptides and methods of use thereof

Cue Biopharma, Inc. Β· Granted Tue Dec 20 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 15 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11505591

T-cell modulatory multimeric polypeptides and methods of use thereof

Cue Biopharma, Inc. Β· Granted Tue Nov 22 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 17 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11505588

T-cell modulatory multimeric polypeptides and methods of use thereof

Cue Biopharma, Inc. Β· Granted Tue Nov 22 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 17 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11401314

T-cell modulatory multimeric polypeptides and methods of use thereof

Cue Biopharma, Inc. Β· Granted Tue Aug 02 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 28 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11401306

HPV16 non HLA-restricted t-cell vaccines, compositions and methods of use thereof

PDS Biotechnology Corporation Β· Granted Tue Aug 02 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 28 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11385233

Methods of depleting malignant T-cells

AUTOLUS LIMITED Β· Granted Tue Jul 12 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 07 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11377478

T-cell modulatory multimeric polypeptides and methods of use thereof

Cue Biopharma, Inc. Β· Granted Tue Jul 05 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 30 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11370821

T-cell modulatory multimeric polypeptides and methods of use thereof

Cue Biopharma, Inc. Β· Granted Tue Jun 28 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 23 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted